Trevigen/TACS®2 TdT核心套件/4810-30-CK/30样品

价格
¥6380.00
货号:4810-30-CK
浏览量:127
品牌:Trevigen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Description

TACS®2TdTCorekitutilizeTrevigen’suniquecationoptimizationsystemtoenhancelabelingwithinparticulartissues.Thekitalsofeatures aproprietarylabelingbufferthatcontainsnotoxiccomponents(e.g.sodiumcacodylate).AhighlypurifiedformoftheTdTenzymeisincludedfortheenzymaticincorporationofbiotinylatednucleotides.Biotinlabelingisdetectedusingstreptavidin-horserADIshperoxidase,andtheresearcher’schoiceofcolorimetricsubstrates orafluorescentconjugateofstreptavidinmaybeusedforvisualization byepifluorescencemicroscopy.

FEATURES:

  • TdTbasedinsitulabeling.
  • Cationoptimizationforhighsignalandlowbackground.
  • IncludesexclusiveCytonin™permeABIlizationreagent.
  • IncludesTACS-Nuclease™controlreagents.
  • LightmicroscopyorFluorescencemicroscopyoptions.

APPLICATIONS:

  • InsitudetectionofapoptosisbyTUNELinfixedfrozen,paraffinembedded,orplasticembeddedcellsandtissues.
Catalog#4810-30-CKincludes:
CatalogNumberDescriptionQty
4800-30-06Streptavidin-HRP1
4810-30-02TACS®2TdTLabelingBuffer1
4810-30-03TACS®2TdTStopBuffer1
4810-30-04TACS®2TdTdNTP1
4810-30-05TdTEnzyme1
4810-30-0950xCobaltCation1
4810-30-1050xMagnesiumCation1
4810-30-1450xManganeseCation1

 

AutophagyinPancreaticAcinarCellsinCaerulein-treatedMice:ImmunolocalizationofRelatedProteinsandTheirPotentialasMarkersofPancreatitis
Zhang,L.,Zhang,J.,Shea,L.,Xu,L.,Tobin,G.,Knapton,A.,Sharron,S.,andRouse,R.
ToxicolPathol,Feb2014;42:435–457.
http://tpx.sagepub.com/cgi/content/abstract/42/2/435

Smad7inducesplasticityintumor-infiltratingTh17cellsandenablesTNF-alpha-mediatedkillingofcolorectalcancercells

Rizzo,A.,DeMare,V.,Rocchi,C.,Stolfi,C.,Colantoni,A.,Neurath,M.F.,Macdonald,T.T.,Pallone,F.,Monteleone,G.,Fantini,M.C.,
Carcinogenesis,Feb2014;10.1093/carcin/bgu027.
http://carcin.oxfordjournals.org/cgi/content/abstract/bgu027v2

Differentialeffectsof2-and3-seriesE-prostaglandinsoninvitroexpansionofLgr5+colonicstemcells
Fan,Y.Y.,Davidson,L.A.,Callaway,E.S.,Goldsby,J.S.andChapkin,R.S.
Carcinogenesis,Mar2014;35:606-612
http://carcin.oxfordjournals.org/cgi/content/abstract/35/3/606

Trevigen,Inc.是一家发展迅速的生物技术公司,致力于开发用于癌症研究,药物发现,遗传毒理学,再生医学和干细胞研究的产品和技术。我们提供试剂盒和试剂,用于研究DNA损伤和修复,细胞凋亡,氧化应激,癌细胞行为,3D培养和干细胞。该公司获得了美国国立卫生研究院(National Institutes of Health)多项SBIR资助。